Serological Screening of the Schistosoma mansoni Adult Worm Proteome

PLoS Neglected Tropical Diseases

Volumn 8, Issue 3, 2014, Pages

  Ludolf, Fernanda ^a,b   Patrocínio, Paola R ^a   Corrêa Oliveira, Rodrigo ^a,b   Gazzinelli, Andréa ^b,c   Falcone, Franco H ^d   Teixeira Ferreira, André ^a   Perales, Jonas ^a   Oliveira, Guilherme C ^a,b   Silva Pereira, Rosiane A ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b National Institute of Science and Technology in Tropical Diseases INCT DT   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ANNEXIN; ANTIGEN; FILAMIN; HEMOGLOBIN HYDROXYLASE; MAJOR EGG ANTIGEN; PROTEOME; RECOMBINANT PROTEIN; RETICULOCALBIN; TROPONIN T; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; DISEASE TRANSMISSION; IMMUNE RESPONSE; IMMUNITY; IMMUNOREACTIVITY; IN VITRO STUDY; MASS SPECTROMETRY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SCHISTOSOMIASIS MANSONI; SEROLOGY; SERUM CHARACTERISTICS; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING; WORM;

ADULT; ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; IMMUNOBLOTTING; MALE; MASS SPECTROMETRY; PROTEOME; SCHISTOSOMA MANSONI; YOUNG ADULT;

EID: 84897442958     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002745     Document Type: Article

References (102)

1. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J, (2006) Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 6: 411-425.
2. King CH, (2009) Toward the elimination of schistosomiasis. N Engl J Med 360: 106-109.
3. Cioli D, Pica-Mattoccia L, (2003) Praziquantel. Parasitol Res 90 Supp 1: S3-S9.
4. King CH, Sturrock RF, Kariuki HC, Hamburger J, (2006) Transmission control for schistosomiasis- why it matters now. Trends Parasitol 22: 575-582.
5. Richter J, (2003) The impact of chemotherapy on morbidity due to schistosomiasis. Acta Trop 86: 161-183.
6. Wang W, Wang L, Liang YS, (2012) Susceptibility or resistance of praziquantel in human schistosomiasis: a review. Parasitol Res 111: 1871-1877.
7. Bergquist R, Al-Sherbiny M, Barakat R, Olds R, (2002) Blueprint for schistosomiasis vaccine development. Acta Trop 82: 183-192.
8. Capron A, Riveau G, Capron M, Trottein F, (2005) Schistosomes: the road from host-parasite interactions to vaccines in clinical trials. Trends Parasitol 21: 143-149.
9. Wilson RA, Curwen RS, Braschi S, Hall SL, Coulson PS, et al. (2004) From genomes to vaccines via the proteome. Mem Inst Oswaldo Cruz 99: 45-50.
10. McWilliam HEG, Driguez P, Piedrafita D, McManus DP, Meeusen ENT, (2012) Novel immunomic technologies for schistosome vaccine development. Parasite Immunology 34: 276-284.
11. McManus DP, Loukas A, (2008) Current status of vaccines for schistosomiasis. Clin Microbiol Rev 21: 225-242.
12. Coulson PS, (1997) The radiation-attenuated vaccine against schistosomes in animal models: Paradigm for a human vaccine? Adv Parasitol 39: 271-336.
13. Tendler M, Simpson AJG, (2008) The biotechnology-value chain: Development of SmA as a schistosomiasis vaccine. Acta Trop 108: 263-266.
14. Kupferschmidt K, (2013) A worm vaccine, coming at a snail's pace. Science 339: 502-503.
15. Riveau G, Deplanque D, Remoue F, Schacht AM, Vodougnon H, et al. (2012) Safety and immunogenicity of rSh28GST antigen in humans: Phase 1 randomized clinical study of a vaccine candidate against urinary schistosomiasis. PloS Negl Trop Dis 6 (7) (): e1704.
16. Tran MH, Pearson MS, Jeffrey MB, Smyth DJ, Jones MK, et al. (2006) Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis. Nat Med 12: 835-840.
17. Correa-Oliveira R, Caldas IR, Gazzinelli G, (2000) Natural versus drug-induced resistance in Schistosoma mansoni infection. Parasitol Today 16: 397-399.
18. Gazzinelli G, Viana IR, Bahia-Oliveira LM, Silveira AM, Queiroz CC, et al. (1992) Immunological profiles of patients from endemic areas infected with Schistosoma mansoni. Mem Inst Oswaldo Cruz 87 Suppl 4: 139-142.
19. Kabatereine NB, Vennervald JB, Ouma JH, Kemijumbi J, Butterworth AE, et al. (1999) Adult resistance to schistosomiasis mansoni: age-dependence of reinfection remains constant in communities with diverse exposure patterns. Parasitology 118: 101-105.
20. Black CL, Mwinzi PNM, Muok EMO, Abudho B, Fitzsimmons CM, et al. (2010) Influence of exposure history on the immunology and development of resistance to human schistosomiasis mansoni. PloS Negl Trop Dis 4 (3) (): e637.
21. Woolhouse MEJ, Hagan P, (1999) Seeking the ghost of worms past. Nat Med 5: 1225-1227.
22. Correa-Oliveira R, Pearce EJ, Oliveira GC, Golgher DB, Katz N, et al. (1989) The human immune response to defined immunogens of Schistosoma mansoni: elevated antibody levels to paramyosin in stool-negative individuals from two endemic areas in Brazil. Trans R Soc Trop Med Hyg 83: 798-804.
23. Viana IRC, Correa-Oliveira R, Dossantos O, Massara CL, Colosimo E, et al. (1995) Comparison of antibody isotype responses to Schistosoma mansoni antigens by infected and putative resistant individuals living in an endemic area. Parasite Immunol 17: 297-304.
24. Bethony JM, Cole RN, Guo XT, Kamhawi S, Lightowlers MW, et al. (2011) Vaccines to combat the neglected tropical diseases. Immunol Rev 239: 237-270.
25. Oliveira SC, Fonseca CT, Cardoso FC, Farias LP, Leite LC, (2008) Recent advances in vaccine research against schistosomiasis in Brazil. Acta Trop 108: 256-262.
26. Driguez P, Doolan DL, Loukas A, Felgner PL, McManus DP, (2010) Schistosomiasis vaccine discovery using immunomics. Parasit Vectors 3: 4.
27. Katz N, Coelho PMZ, Pellegrino J, (1970) Evaluation of katos quantitative method through recovery of Schistosoma mansoni eggs added to human feces. J Parasitol 56: 1032-3.
28. Gray DJ, Ross AG, Li YS, McManus DP, (2011) Diagnosis and management of schistosomiasis. BMJ 342: d2651.
29. Gryseels B, Polman K, Clerinx J, Kestens L, (2006) Human schistosomiasis. Lancet 368: 1106-1118.
30. Zhong ZR, Zhou HB, Li XY, Luo QL, Song XR, et al. (2010) Serological proteome-oriented screening and application of antigens for the diagnosis of Schistosomiasis japonica. Acta Trop 116: 1-8.
31. Curwen RS, Ashton PD, Johnston DA, Wilson RA, (2004) The Schistosoma mansoni soluble proteome: a comparison across four life-cycle stages. Mol Biochem Parasitol 138: 57-66.
32. Liu F, Lu J, Hu W, Wang SY, Cui SJ, et al. (2006) New perspectives on host-parasite interplay by comparative transcriptomic and proteomic analyses of Schistosoma japonicum. PLoS Pathog 2: e29.
33. Mathieson W, Wilson RA, (2010) A comparative proteomic study of the undeveloped and developed Schistosoma mansoni egg and its contents: the miracidium, hatch fluid and secretions. Int J Parasitol 40: 617-628.
34. Cheng GF, Lin JJ, Feng XG, Fu ZQ, Jin YM, et al. (2005) Proteomic analysis of differentially expressed proteins between the male and female worm of Schistosoma japonicum after pairing. Proteomics 5: 511-521.
35. Yang LL, Lv ZY, Hu SM, He SJ, Li ZY, et al. (2009) Schistosoma japonicum: proteomics analysis of differentially expressed proteins from ultraviolet-attenuated cercariae compared to normal cercariae. Parasitol Res 105: 237-248.
36. Braschi S, Curwen RS, Ashton PD, Verjovski-Almeida S, Wilson A, (2006) The tegument surface membranes of the human blood parasite Schistosoma mansoni: a proteomic analysis after differential extraction. Proteomics 6: 1471-1482.
37. Braschi S, Wilson RA, (2006) Proteins exposed at the adult schistosome surface revealed by biotinylation. Mol Cell Proteomics 5: 347-356.
38. Perez-Sanchez R, Ramajo-Hernandez A, Ramajo-Martin V, Oleaga A, (2006) Proteomic analysis of the tegument and excretory-secretory products of adult Schistosoma bovis worms. Proteomics 6 Suppl 1: S226-S236.
39. Perez-Sanchez R, Valero ML, Ramajo-Hernandez A, Siles-Lucas M, Ramajo-Martin V, et al. (2008) A proteomic approach to the identification of tegumental proteins of male and female Schistosoma bovis worms. Mol Biochem Parasitol 161: 112-123.
40. van Balkom BW, van Gestel RA, Brouwers JF, Krijgsveld J, Tielens AG, et al. (2005) Mass spectrometric analysis of the Schistosoma mansoni tegumental sub-proteome. J Proteome Res 4: 958-966.
41. Castro-Borges W, Dowle A, Curwen RS, Thomas-Oates J, Wilson RA, (2011) Enzymatic shaving of the tegument surface of live schistosomes for proteomic analysis: a rational approach to select vaccine candidates. PloS Negl Trop Dis 5 (3) (): e993.
42. Castro-Borges W, Simpson DM, Dowle A, Curwen RS, Thomas-Oates J, et al. (2011) Abundance of tegument surface proteins in the human blood fluke Schistosoma mansoni determined by QconCAT proteomics. J of Proteomics 74: 1519-1533.
43. Cass CL, Johnson JR, Califf LL, Xu T, Hernandez HJ, et al. (2007) Proteomic analysis of Schistosoma mansoni egg secretions. Mol Biochem Parasitol 155: 84-93.
44. Curwen RS, Ashton PD, Sundaralingam S, Wilson RA, (2006) Identification of novel proteases and immunomodulators in the secretions of schistosome cercariae that facilitate host entry. Mol Cell Proteomics 5: 835-844.
45. Guillou F, Roger E, Mone Y, Rognon A, Grunau C, et al. (2007) Excretory-secretory proteome of larval Schistosoma mansoni and Echinostoma caproni, two parasites of Biomphalaria glabrata. Mol Biochem Parasitol 155: 45-56.
46. Hansell E, Braschi S, Medzihradszky KF, Sajid M, Debnath M, et al. (2008) Proteomic analysis of skin invasion by blood fluke larvae. PLoS Negl Trop Dis 2: e262.
47. Knudsen GM, Medzihradszky KF, Lim KC, Hansell E, McKerrow JH, (2005) Proteomic analysis of Schistosoma mansoni cercarial secretions. Mol Cell Proteomics 4: 1862-1875.
48. Liu F, Cui SJ, Hu W, Feng Z, Wang ZQ, et al. (2009) Excretory/secretory proteome of the adult developmental stage of human blood fluke, Schistosoma japonicum. Mol Cell Proteomics 8: 1236-1251.
49. Wu XJ, Sabat G, Brown JF, Zhang M, Taft A, et al. (2009) Proteomic analysis of Schistosoma mansoni proteins released during in vitro miracidium-to-sporocyst transformation. Mol Biochem Parasitol 164: 32-44.
50. Seliger B, Kellner R, (2002) Design of proteome-based studies in combination with serology for the identification of biomarkers and novel targets. Proteomics 2: 1641-1651.
51. Jungblut PR, Zimny-Arndt U, Zeindl-Eberhart E, Stulik J, Koupilova K, et al. (1999) Proteomics in human disease: cancer, heart and infectious diseases. Electrophoresis 20: 2100-2110.
52. Haas G, Karaali G, Ebermayer K, Metzger WG, Lamer S, et al. (2002) Immunoproteomics of Helicobacter pylori infection and relation to gastric disease. Proteomics 2: 313-324.
53. Mendum TA, Newcombe J, McNeilly CL, McFadden J, (2009) Towards the immunoproteome of Neisseria meningitidis. PLoS One 4: e5940.
54. Coelho VTS, Oliveira JS, Valadares DG, Chaves-Fumagalli MA, Duarte MC, et al. (2012) Identification of proteins in promastigote and amastigote-like Leishmania using an immunoproteomic approach. PLoS Negl Trop Dis 6: e1430.
55. Higon M, Cowan G, Nausch N, Cavanagh D, Oleaga A, et al. (2011) Screening trematodes for novel intervention targets: a proteomic and immunological comparison of Schistosoma haematobium, Schistosoma bovis and Echinostoma caproni. Parasitology 138: 1607-1619.
56. Mark HF, el-Sherbeini M, Goldberg M, Suri PK, Sturley SL, et al. (1991) Schistosoma mansoni: two-dimensional gel electrophoretic analysis of antigens uniquely immunoreactive with protective rat serum. Exp Parasitol 72: 294-305.
57. Wilson RA, Langermans JA, van Dam GJ, Vervenne RA, Hall SL, et al. (2008) Elimination of Schistosoma mansoni adult worms by Rhesus macaques: basis for a therapeutic vaccine? PLoS Negl Trop Dis 2: e290.
58. Mutapi F, Burchmore R, Mduluza T, Midzi N, Turner CM, et al. (2008) Age-related and infection intensity-related shifts in antibody recognition of defined protein antigens in a schistosome-exposed population. J Infect Dis 198: 167-175.
59. Mutapi F, Burchmore R, Mduluza T, Foucher A, Harcus Y, et al. (2005) Praziquantel treatment of individuals exposed to Schistosoma haematobium enhances serological recognition of defined parasite antigens. J of Infect Dis 192: 1108-1118.
60. Mutapi F, Bourke C, Harcus Y, Midzi N, Mduluza T, et al. (2011) Differential recognition patterns of Schistosoma haematobium adult worm antigens by the human antibodies IgA, IgE, IgG1 and IgG4. Parasite Immunol 33: 181-192.
61. Pellegrino J, Siqueira A, (1956) A perfusion technic for recovery of Schistosoma mansoni from experimentally infected guinea pigs. Rev Bras Malariol Doencas Trop 8: 589-597.
62. Roberts SM, Macgregor AN, Vojvodic M, Wells E, Crabtree JE, et al. (1983) Tegument surface membranes of adult Schistosoma mansoni- Development of a method for their isolation. Mol Biochem Parasitol 9: 105-127.
63. Babu GJ, Wheeler D, Alzate O, Periasamy M, (2004) Solubilization of membrane proteins for two-dimensional gel electrophoresis: identification of sarcoplasmic reticulum membrane proteins. Anal Biochem 325: 121-125.
64. Bradford MM, (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
65. Laemmli UK, (1970) Cleavage of Structural Proteins During Assembly of Head of Bacteriophage-T4. Nature 227: 680-.
66. Pereira WR, Kloos H, Crawford SB, Velasquez-Melendez JG, Matoso LF, et al. (2010) Schistosoma mansoni infection in a rural area of the Jequitinhonha Valley, Minas Gerais, Brazil: analysis of exposure risk. Acta Trop 113: 34-41.
67. Zerlotini A, Aguiar ERGR, Yu FD, Xu HY, Li YX, et al. (2013) SchistoDB: an updated genome resource for the three key schistosomes of humans. Nucleic Acids Res 41: D728-D731.
68. Reich M, Liefeld T, Gould J, Lerner J, Tamayo P, et al. (2006) GenePattern 2.0. Nat Genet 38: 500-501.
69. Wilson RA, Coulson PS, (2009) Immune effector mechanisms against schistosomiasis: looking for a chink in the parasite's armour. Trends Parasitol 25: 423-431.
70. Jankovic D, Wynn TA, Kullberg MC, Hieny S, Caspar P, et al. (1999) Optimal vaccination against Schistosoma mansoni requires the induction of both B cell- and IFN-gamma-dependent effector mechanisms. J Immunol 162: 345-351.
71. Mutapi F, (2001) Heterogeneities in anti-schistosome humoral responses following chemotherapy. Trends in Parasitol 17: 518-524.
72. Agnew AM, Murare HM, Doenhoff MJ, (1993) Immune attrition of adult schistosomes. Parasite Immunol 15: 261-271.
73. Boukli NM, Delgado B, Ricaurte M, Espino AM, (2011) Fasciola hepatica and Schistosoma mansoni: Identification of common proteins by comparative proteomic analysis. J of Parasitol 97: 852-861.
74. Reynolds SR, Dahl CE, Harn DA, (1994) T and B epitope determination and analysis of multiple antigenic peptides for the Schistosoma mansoni experimental vaccine triose-phosphate isomerase. J Immunol 152: 193-200.
75. Capron A, Riveau G, Grzych JM, Boulanger D, Capron M, et al. (1994) Development of a vaccine strategy against human and bovine schistosomiasis. Background and update. Trop Geogr Med 46: 242-246.
76. Shalaby KA, Yin L, Thakur A, Christen L, Niles EG, et al. (2003) Protection against Schistosoma mansoni utilizing DNA vaccination with genes encoding Cu/Zn cytosolic superoxide dismutase, signal peptide-containing superoxide dismutase and glutathione peroxidase enzymes. Vaccine 22: 130-136.
77. Diemert DJ, Pinto AG, Freire J, Jariwala A, Santiago H, et al. (2012) Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: Implications for the development of vaccines against helminths. J Allergy and Clin Immunol 130: 169-176.e6.
78. Delgado VS, Mclaren DJ, (1990) Evidence that radio-sensitive cells are central to skin-phase protective immunity in Cba/Ca mice vaccinated with radiation-attenuated cercariae of Schistosoma mansoni as well as in naive mice protected with vaccine serum. Parasitology 100: 45-56.
79. Rabilloud T, (2009) Membrane proteins and proteomics: Love is possible, but so difficult. Electrophoresis 30: S174-S180.
80. Losada S, Chacon N, Colmenares C, Bermudez H, Lorenzo A, et al. (2005) Schistosoma: cross-reactivity and antigenic community among different species. Exp Parasitol 111: 182-190.
81. Bahgat M, Maghraby AS, Ab Del-Fatah OM, Elshafei AM, (2005) Immunization of mice with crude extract of Saccharomyces boulardii yeast induces cross-reactive immune responses with antigenic preparations from different developmental stages of the Schistosoma mansoni and reduces the parasite worm burden. J Egypt Soc Parasitol 35: 563-580.
82. Bahgat MM, Gaber HM, Maghraby AS, (2009) Escherichia coli shares T- and B-lymphocyte epitopes with Schistosoma mansoni. J Infect Dev Ctries 3: 206-217.
83. Protasio AV, Tsai IJ, Babbage A, Nichol S, Hunt M, et al. (2012) A systematically improved high quality genome and transcriptome of the human blood fluke Schistosoma mansoni. PloS Negl Trop Dis 6 (1) (): e1455.
84. Cao M, Chao H, Doughty BL, (1993) Cloning of a cdna-encoding an egg antigen homolog from Schistosoma mansoni. Mol Biochem Parasitol 58: 169-171.
85. Abouel-Nour MF, Lotfy M, Attallah AM, Doughty BL, (2006) Schistosoma mansoni major egg antigen Smp40: molecular modeling and potential immunoreactivity for anti-pathology vaccine development. Mem Inst Oswaldo Cruz 101: 365-372.
86. Nene V, Dunne DW, Johnson KS, Taylor DW, Cordingley JS, (1986) Sequence and expression of a major egg antigen from Schistosoma mansoni- homologies to heat-shock proteins and alpha-crystallins. Mol Biochem Parasitol 21: 179-188.
87. Cordingley JS, Taylor DW, Dunne DW, Butterworth AE, (1983) Clone banks of cdna from the parasite Schistosoma mansoni- isolation of clones containing a potentially immunodiagnostic antigen gene. Gene 26: 25-39.
88. Stossel TP, Condeelis J, Cooley L, Hartwig JH, Noegel A, et al. (2001) Filamins as integrators of cell mechanics and signalling. Nat Rev Mol Cell Biol 2: 138-145.
89. Feng YY, Walsh CA, (2004) The many faces of filamin: a versatile molecular scaffold for cell motility and signalling. Nat Cell Biol 6: 1034-1038.
90. Mohamed MR, Shalaby KA, LoVerde PT, Allah NMA, Karim AM, (2008) Cloning and characterization of a cDNA fragment encoding a Schistosoma mansoni actin-binding protein (Smfilamin). Parasitol Res 102: 1035-1042.
91. Cook RM, Carvalho-Queiroz C, Wilding G, LoVerde PT, (2004) Nucleic acid vaccination with Schistosoma mansoni antioxidant enzyme cytosolic superoxide dismutase and the structural protein filamin confers protection against the adult worm stage. Infect Immun 72: 6112-6124.
92. Wei B, Jin JP, (2011) Troponin T isoforms and posttranscriptional modifications: Evolution, regulation and function. Arch Biochem Biophys 505: 144-154.
93. Mayta H, Hancock K, Gilman RH, Zamudio R, Castillo JP, et al. (2009) A novel Taenia solium protein that resembles troponin T proteins. J Parasitol 95: 591-597.
94. Oliveira GC, Kemp WM, (1995) Cloning of two actin genes from Schistosoma mansoni. Mol Biochem Parasitol 75: 119-122.
95. Fukuda T, Oyamada H, Isshiki T, Maeda M, Kusakabe T, et al. (2007) Distribution and variable expression of secretory pathway protein reticulocalbin in normal human organs and non-neoplastic pathological conditions. J Histochem Cytochem 55: 335-345.
96. Taratam CA, Farias LP, Wilson RA, Leite LCD, (2010) Schistosoma mansoni Annexin 2: Molecular characterization and immunolocalization. Exp Parasitol 126: 146-155.
97. Escudero ED, Manzano-Roman R, Valero L, Oleaga A, Perez-Sanchez R, et al. (2011) Comparative proteomic analysis of Fasciola hepatica juveniles and Schistosoma bovis schistosomula. J Proteomics 74: 1534-1544.
98. Wippersteg V, Ribeiro F, Liedtke S, Kusel JR, Grevelding CG, (2003) The uptake of Texas Red-BSA in the excretory system of schistosomes and its colocalisation with ER60 promoter-induced GFP in transiently transformed adult males. Int J Parasitol 33: 1139-1143.
99. Wippersteg V, Kapp K, Kunz W, Grevelding CG, (2002) Characterisation of the cysteine protease ER60 in transgenic Schistosoma mansoni larvae. Int J Parasitol 32: 1219-1224.
100. Mateyak MK, Kinzy TG, (2010) eEF1A: thinking outside the ribosome. J Biol Chem 285: 21209-21213.
101. Margutti P, Ortona E, Vaccari S, Barca S, Rigano R, et al. (1999) Cloning and expression of a cDNA encoding an elongation factor 1 beta/delta protein from Echinococcus granulosus with immunogenic activity. Parasite Immunol 21: 485-492.
102. Krah A, Jungblut PR, (2004) Immunoproteomics. Methods Mol Med 94: 19-32.